These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 17116678)
1. Leishmania donovani polyamine biosynthetic enzyme overproducers as tools to investigate the mode of action of cytotoxic polyamine analogs. Roberts SC; Jiang Y; Gasteier J; Frydman B; Marton LJ; Heby O; Ullman B Antimicrob Agents Chemother; 2007 Feb; 51(2):438-45. PubMed ID: 17116678 [TBL] [Abstract][Full Text] [Related]
2. S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers. Roberts SC; Scott J; Gasteier JE; Jiang Y; Brooks B; Jardim A; Carter NS; Heby O; Ullman B J Biol Chem; 2002 Feb; 277(8):5902-9. PubMed ID: 11734561 [TBL] [Abstract][Full Text] [Related]
3. Effects of pentamidine on polyamine level and biosynthesis in wild-type, pentamidine-treated, and pentamidine-resistant Leishmania. Basselin M; Badet-Denisot MA; Lawrence F; Robert-Gero M Exp Parasitol; 1997 Mar; 85(3):274-82. PubMed ID: 9085924 [TBL] [Abstract][Full Text] [Related]
4. RNA interference-mediated silencing of ornithine decarboxylase and spermidine synthase genes in Trypanosoma brucei provides insight into regulation of polyamine biosynthesis. Xiao Y; McCloskey DE; Phillips MA Eukaryot Cell; 2009 May; 8(5):747-55. PubMed ID: 19304951 [TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of spermidine synthase from Leishmania donovani. Roberts SC; Jiang Y; Jardim A; Carter NS; Heby O; Ullman B Mol Biochem Parasitol; 2001 Jul; 115(2):217-26. PubMed ID: 11420108 [TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha-difluoromethylornithine resistant Leishmania donovani and its susceptibility to other inhibitors of the polyamine biosynthetic pathway. Mukhopadhyay R; Kapoor P; Madhubala R Pharmacol Res; 1996; 34(1-2):43-6. PubMed ID: 8981555 [TBL] [Abstract][Full Text] [Related]
7. Effects of bis(benzyl)polyamine analogs on Leishmania donovani promastigotes. Mukhopadhyay R; Madhubala R Exp Parasitol; 1995 Aug; 81(1):39-46. PubMed ID: 7628565 [TBL] [Abstract][Full Text] [Related]
8. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion. Singh S; Mukherjee A; Khomutov AR; Persson L; Heby O; Chatterjee M; Madhubala R Antimicrob Agents Chemother; 2007 Feb; 51(2):528-34. PubMed ID: 17101681 [TBL] [Abstract][Full Text] [Related]
9. Antileishmanial effect of a potent S-adenosylmethionine decarboxylase inhibitor: CGP 40215A. Mukhopadhyay R; Kapoor P; Madhubala R Pharmacol Res; 1996 Jan; 33(1):67-70. PubMed ID: 8817649 [TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. Boitz JM; Yates PA; Kline C; Gaur U; Wilson ME; Ullman B; Roberts SC Infect Immun; 2009 Feb; 77(2):756-63. PubMed ID: 19064633 [TBL] [Abstract][Full Text] [Related]
11. Spermidine synthase is required for virulence of Leishmania donovani. Gilroy C; Olenyik T; Roberts SC; Ullman B Infect Immun; 2011 Jul; 79(7):2764-9. PubMed ID: 21536795 [TBL] [Abstract][Full Text] [Related]
12. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity. Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani. Hazra S; Ghosh S; Das Sarma M; Sharma S; Das M; Saudagar P; Prajapati VK; Dubey VK; Sundar S; Hazra B Exp Parasitol; 2013 Oct; 135(2):407-13. PubMed ID: 23973194 [TBL] [Abstract][Full Text] [Related]
14. Regulated expression of an essential allosteric activator of polyamine biosynthesis in African trypanosomes. Willert EK; Phillips MA PLoS Pathog; 2008 Oct; 4(10):e1000183. PubMed ID: 18949025 [TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase gene deletion mutants of Leishmania donovani. Jiang Y; Roberts SC; Jardim A; Carter NS; Shih S; Ariyanayagam M; Fairlamb AH; Ullman B J Biol Chem; 1999 Feb; 274(6):3781-8. PubMed ID: 9920931 [TBL] [Abstract][Full Text] [Related]
16. Antiparasitic chemotherapy: tinkering with the purine salvage pathway. Datta AK; Datta R; Sen B Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663 [TBL] [Abstract][Full Text] [Related]
17. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Heby O; Persson L; Rentala M Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127 [TBL] [Abstract][Full Text] [Related]
18. A quantitative proteomic screen to identify potential drug resistance mechanism in α-difluoromethylornithine (DFMO) resistant Leishmania donovani. Singh AK; Roberts S; Ullman B; Madhubala R J Proteomics; 2014 May; 102():44-59. PubMed ID: 24631822 [TBL] [Abstract][Full Text] [Related]
19. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Shantz LM; Pegg AE Cancer Res; 1994 May; 54(9):2313-6. PubMed ID: 8162572 [TBL] [Abstract][Full Text] [Related]